Evidence map›Paper›PMID 33609503›Full record

ArticleGastroenterology2021

Development and Validation of a Novel Computed-Tomography Enterography Radiomic Approach for Characterization of Intestinal Fibrosis in Crohn's Disease.

Xuehua Li, Dong Liang, Jixin Meng, Jie Zhou, Zhao Chen, Siyun Huang, Baolan Lu, Yun Qiu, Mark E Baker, Ziyin Ye and 15 more

Registry-linked trialAbstract readMulticenter StudyValidation Study
In one paragraph

Article in Gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06858553 (A Prospective, Multi-center Study to Characterize Intestinal Fibrosis in Patients With Crohn's Disease), which is not on this map. Cited by 70 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06858553 recruitingnot on this mapstarted 2025, after this paper: background citation

A Prospective, Multi-center Study to Characterize Intestinal Fibrosis in Patients With Crohn's Disease (CD) Using MR Enterography (MRE)-Based Artificial Intelligence

Typeobservational_patient_registrySponsorMinhu ChenRan2025 to 2027Enrolled234ConditionsCrohn Disease (CD)
3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Artificial intelligence in the management of inflammatory bowel disease: What's next?World journal of gastrointestinal pharmacology and therapeutics · 2026
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. The functional role of the extracellular matrix in inflammatory bowel disease associated gut fibrosis.Matrix biology : journal of the International Society for Matrix Biology · 2025
    Review
  17. Article
  18. Review
  19. Artificial intelligence in inflammatory bowel disease.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2025
    Review
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Xuehua LiDepartment of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.
Dong LiangMedical AI Lab, School of Biomedical Engineering, Health Science Center, Shenzhen University, People's Republic of China.
Jixin MengDepartment of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.
Jie ZhouDepartment of Radiology, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.
Zhao ChenDepartment of Medical Imaging Center, Nan Fang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Siyun HuangDepartment of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.
Baolan LuDepartment of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.
Yun QiuDepartment of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.
Mark E BakerSection of Abdominal Imaging, Imaging Institute, Digestive Disease Institute and Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
Ziyin YeDepartment of Pathology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.
Qinghua CaoDepartment of Pathology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.
Mingyu WangMedical AI Lab, School of Biomedical Engineering, Health Science Center, Shenzhen University, People's Republic of China.
Chenglang YuanMedical AI Lab, School of Biomedical Engineering, Health Science Center, Shenzhen University, People's Republic of China.
Zhihui ChenDepartment of Gastrointestinal and Pancreatic Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.
Shengyu FengMedical AI Lab, School of Biomedical Engineering, Health Science Center, Shenzhen University, People's Republic of China.
Yuxuan ZhangMedical AI Lab, School of Biomedical Engineering, Health Science Center, Shenzhen University, People's Republic of China.
Marietta IacucciNational Institute for Health Research Biomedical Research Institute, Institute of Translational Medicine, University of Birmingham, University Hospitals Birmingham National Health Service Foundation Trust, United Kingdom.
Subrata GhoshNational Institute for Health Research Biomedical Research Institute, Institute of Translational Medicine, University of Birmingham, University Hospitals Birmingham National Health Service Foundation Trust, United Kingdom.
Florian RiederDepartment of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, Ohio.
Canhui SunDepartment of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.
Minhu ChenDepartment of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.
Ziping LiDepartment of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.
Ren MaoDepartment of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China; Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address: maor5@mail.sysu.edu.cn.
Bingsheng HuangMedical AI Lab, School of Biomedical Engineering, Health Science Center, Shenzhen University, People's Republic of China. Electronic address: huangb@szu.edu.cn.
Shi-Ting FengDepartment of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China. Electronic address: fengsht@mail.sysu.edu.cn.

Funding

Creeping fat and Crohn's disease associated stricturesR01DK123233 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI RIEDER, FLORIAN · 2020 to 2024
$1.9M
Microbiota in Intestinal FibrosisK08DK110415 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI RIEDER, FLORIAN · 2016 to 2020
$767k
NIDDK NIH HHS K08 DK110415NIDDK NIH HHS R01 DK123233
6 · The paper itself

Abstract

BACKGROUND &

aimsNo reliable method for evaluating intestinal fibrosis in Crohn's disease (CD) exists; therefore, we developed a computed-tomography enterography (CTE)-based radiomic model (RM) for characterizing intestinal fibrosis in CD.

methodsThis retrospective multicenter study included 167 CD patients with 212 bowel lesions (training, 98 lesions; test, 114 lesions) who underwent preoperative CTE and bowel resection at 1 of the 3 tertiary referral centers from January 2014 through June 2020. Bowel fibrosis was histologically classified as none-mild or moderate-severe. In the training cohort, 1454 radiomic features were extracted from venous-phase CTE and a machine learning-based RM was developed based on the reproducible features using logistic regression. The RM was validated in an independent external test cohort recruited from 3 centers. The diagnostic performance of RM was compared with 2 radiologists' visual interpretation of CTE using receiver operating characteristic (ROC) curve analysis.

resultsIn the training cohort, the area under the ROC curve (AUC) of RM for distinguishing moderate-severe from none-mild intestinal fibrosis was 0.888 (95% confidence interval [CI], 0.818-0.957). In the test cohort, the RM showed robust performance across 3 centers with an AUC of 0.816 (95% CI, 0.706-0.926), 0.724 (95% CI, 0.526-0.923), and 0.750 (95% CI, 0.560-0.940), respectively. Moreover, the RM was more accurate than visual interpretations by either radiologist (radiologist 1, AUC = 0.554; radiologist 2, AUC = 0.598; both, P < .001) in the test cohort. Decision curve analysis showed that the RM provided a better net benefit to predicting intestinal fibrosis than the radiologists.

conclusionsA CTE-based RM allows for accurate characterization of intestinal fibrosis in CD.

Indexed as

AdultCrohn DiseaseFemaleFibrosisHumansIntestinesLogistic ModelsMaleMiddle AgedPredictive Value of TestsReproducibility of ResultsRetrospective StudiesROC CurveSeverity of Illness IndexTomography, X-Ray ComputedComputed Tomography EnterographyCrohn’s DiseaseFibrosisRadiomics

Identifiers

PMID33609503
PMCPMC8903088

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.